April 2, 2020 02:33 pm GMT
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/QH2Aybayk6A/
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential treatment for COVID-19. The company, which has raised at least $290 million to date (according to Crunchbase), uses “Natural Killer” (NK) cell therapies to boost […]Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/QH2Aybayk6A/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch